Jun 22 Open Letter from Gilead CEO Daniel O'Day | Stories@Gilead
Gilead begins clinical study of inhaled remdesivir for COVID-19 treatment | AHA News
In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters - ScienceDirect
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions | Reuters
Gilead announces long-awaited price for Covid-19 drug remdesivir - STAT
Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir
Inhaled formulation of remdesivir enters clinical trials
Pharmaceutics | Free Full-Text | Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Gilead's next COVID-19 treatment advancement could keep patients out of hospitals | Fortune
Researchers develop dry powder remdesivir to strike COVID-19 where it counts | Fierce Pharma
Inhaled Remdesivir for Home Use for Covid Treatment
Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir
Gilead to Test a Version of Remdesivir That Can Be Inhaled - The New York Times
Gilead to Begin Human Testing of Inhaled Version of Covid-19 Drug Remdesivir - WSJ
Frontiers | Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
Gilead to study inhaled remdesivir on COVID-19 patients
Gilead Tests An Inhalable Form of Intravenous Remdesivir | Time
Gilead kicks off clinical trial of inhaled remdesivir for less-severe COVID-19 | Fierce Pharma
Gilead's Inhaled COVID-19 Treatment, Remdesivir, Requires More Adequate Testing Before Regulatory Approval | BioSpace
Gilead launches clinical trial of coronavirus-fighting remdesivir inhaled version | Fox Business
Inhaled formulation of remdesivir to be tested as COVID-19 treatment
Coronavirus: WHO tells doctors don't use Gilead's remdesivir, splitting with FDA
How a family's remdesivir hunt reshaped a state Covid-19 response - STAT
Gilead begins testing of inhaled version of remdesivir for Covid-19
Gilead Sciences to start trials of inhaled version of remdesivir
